Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211–25.

Article  CAS  PubMed  Google Scholar 

Fleuren EDG, Zhang LX, Wu JM, Daly RJ. The kinome ‘at large’ in cancer. Nat Rev Cancer. 2016;16:83–98.

Article  CAS  PubMed  Google Scholar 

Li SG, Ilaria RL, Million RP, Daley GQ, Van Etten RA. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med. 1999;189:1399–412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391–405.

Article  CAS  PubMed  Google Scholar 

Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M, et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children’s oncology group study. J Clin Oncol. 2009;27:5175–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Slayton WB, Schultz KR, Kairalla JA, Devidas M, Mi XL, Pulsipher MA, et al. Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome-positive acute lymphoblastic leukemia: results of children’s oncology group trial AALL0622. J Clin Oncol. 2018;36:2306.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Drilon A, Laetsch TW, Kummar S, DuBois SG, Lassen UN, Demetri GD, et al. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018;378:731–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics. Med Res Rev. 2014;34:280–300.

Article  CAS  PubMed  Google Scholar 

Schuler M, Cho BC, Sayehli CM, Navarro A, Soo RA, Richly H, et al. Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study. Lancet Oncol. 2019;20:1454–66.

Article  CAS  PubMed  Google Scholar 

Ma X, Liu Y, Liu Y, Alexandrov LB, Edmonson MN, Gawad C, et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature. 2018;555:371–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, et al. The landscape of genomic alterations across childhood cancers. Nature. 2018;555:321–7.

Article  PubMed  Google Scholar 

Wong M, Mayoh C, Lau LMS, Khuong-Quang D-A, Pinese M, Kumar A, et al. Whole genome, transcriptome and methylome profiling enhances actionable target discovery in high-risk pediatric cancer. Nat Med. 2020;26:1742–53.

Article  CAS  PubMed  Google Scholar 

Newman S, Nakitandwe J, Kesserwan CA, Azzato EM, Wheeler DA, Rusch M, et al. Genomes for Kids: the scope of pathogenic mutations in pediatric cancer revealed by comprehensive DNA and RNA sequencing. Cancer Discov. 2021;11:3008–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harttrampf AC, Lacroix L, Deloger M, Deschamps F, Puget S, Auger N, et al. Molecular screening for cancer treatment optimization (MOSCATO-01) in pediatric patients: a single-institutional prospective molecular stratification trial. Clin Cancer Res. 2017;23:6101.

Article  CAS  PubMed  Google Scholar 

van Tilburg CM, Pfaff E, Pajtler KW, Langenberg KPS, Fiesel P, Jones BC, et al. The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets. Cancer Discov. 2021;11:2764–79. candisc.0094.2021

Article  PubMed  PubMed Central  Google Scholar 

Berlanga P, Pierron G, Lacroix L, Chicard M, de Beaumais TA, Marchais A, et al. The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. Cancer Discov. 2022;12:1266–81.

Article  PubMed  PubMed Central  Google Scholar 

Sarthy JF, Reddivalla N, Radhi M, Chastain K. Pediatric 8p11 eosinophilic myeloproliferative syndrome (EMS): a case report and review of the literature. Pediatr Blood Cancer. 2017;64:e26310.

Article  Google Scholar 

Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, et al. Erdafitinib in locally advanced or metastatic urothelial carcinoma. N. Engl J Med. 2019;381:338–48.

Article  CAS  PubMed  Google Scholar 

Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21:671–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deng CX, Wynshawboris A, Shen MM, Daugherty C, Ornitz DM, Leder P. Murine Fgfr-1 is required for early postimplantation growth and axial organization. Genes Dev. 1994;8:3045–57.

Article  CAS  PubMed  Google Scholar 

Arman E, Haffner-Krausz R, Chen Y, Heath JK, Lonai P. Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. Proc Natl Acad Sci USA. 1998;95:5082–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet. 1996;12:390–7.

Article  CAS  PubMed  Google Scholar 

Weinstein M, Xu XL, Ohyama K, Deng CX. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development. 1998;125:3615–23.

Article  CAS  PubMed  Google Scholar 

Johnson DE, Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res. 1993;60:1–41.

CAS  PubMed  Google Scholar 

Ornitz DM, Itoh N. The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4:215–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Goetz R, Beenken A, Ibrahimi OA, Kalinina J, Olsen SK, Eliseenkova AV, et al. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol Cell Biol. 2007;27:3417–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Plotnikov AN, Hubbard SR, Schlessinger J, Mohammadi M. Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity. Cell 2000;101:413–24.

Article  CAS  PubMed  Google Scholar 

Tiong KH, Mah LY, Leong C-O. Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers. Apoptosis. 2013;18:1447–68.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Partanen J, Makela TP, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L, et al. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J. 1991;10:1347–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kalinina J, Dutta K, Ilghari D, Beenken A, Goetz R, Eliseenkova AV, et al. The alternatively spliced acid box region plays a key role in FGF receptor autoinhibition. Structure. 2012;20:77–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roghani M, Moscatelli D. Prostate cells express two isoforms of fibroblast growth factor receptor 1 with different affinities for fibroblast growth factor-2. Prostate. 2007;67:115–24.

Article  CAS  PubMed  Google Scholar 

Furdui CM, Lew ED, Schlessinger J, Anderson KS. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Mol cell. 2006;21:711–7.

Article  CAS  PubMed  Google Scholar 

Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16:139–49.

Article  CAS  PubMed  Google Scholar 

Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth-factor receptor (FLG) is a binding-site for the sh2 domain of phospholipase C-GAMMA-1. Mol Cell Biol. 1991;11:5068–78.

CAS  PubMed  PubMed Central  Google Scholar 

Gillani R, Seong BKA, Crowdis J, Conway JR, Dharia NV, Alimohamed S, et al. Gene fusions create partner and collateral dependencies essential to cancer cell survival. Cancer Res. 2021;81:3971–84.

Article